Identifying Individuals at Risk of Glucocorticoid-Induced Impairment of Bone Disease (RIGID
Key facts
- Where
- Esbjerg és Odense C, DániaSee the 2 sites
- Phase
- 2. fázis
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Dánia
- Esbjerg Og Grindsted SygehusEsbjerg, DániaNo longer taking part
- Odense University HospitalOdense C, DániaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Odense University Hospital
- Trial code
- EU 2023-506949-27-00
- Record updated
- 2025. december 5.
- Original description
The main objective of the study is to detect a biomarker(s) that identifies individuals at risk of Glucocorticoid-Induced Impairment of Bone DiseaseRead full original descriptionShow less
Identifying Individuals at Risk of Glucocorticoid-Induced Impairment of Bone Disease (RIGID)
The main objective of the study is to detect a biomarker(s) that identifies individuals at risk of Glucocorticoid-Induced Impairment of Bone Disease
Inclusion: Men and women aged 18-50 years.
Exclusion: Vaccination with living or weaken viral or bacterial vaccines in patient who or immunocompromised. In these cases, prednisolone treatment should not be administered two weeks before and after vaccination; Previous gastric bypass and/or known ongoing malabsorption; Allergy to prednisolone or one of the excipients; Systematic fungal infections; Not able to provide informed consent (e.g., dementia, not able to understand Danish). At the information meeting the investigator will make an individual assessment to evaluate whether a potential study participants understand the information; Known Cushing’s syndrome; Severe covid-19 in the last 3 month (defined as needing dexamethasone treatment); Menopause (defined as 1 year without menstrual bleeding); Ongoing infection; Chronic kidney disease (eGFR <30); Uncontrolled thyrotoxicosis; Use of oral or inhaled GCs within the past year; Pregnancy (defined as elevated HCG).